Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins

International Journal of Pharmaceutics

Volumn 182, Issue 1, 1999, Pages 59-69

  Cavalli, Roberta ^a   Peira, Elena ^a   Caputo, Otto ^a   Gasco, Maria Rosa ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cyclodextrin complexes; Inclusion complexation; Release studies; Solid lipid nanoparticles; Steroid

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; DRUG CARRIER; HYDROCORTISONE; NANOPARTICLE; PROGESTERONE;

ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROEMULSION; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS; BETA-CYCLODEXTRINS; CALORIMETRY, DIFFERENTIAL SCANNING; CYCLODEXTRINS; DRUG CARRIERS; EXCIPIENTS; FREEZE DRYING; HYDROCORTISONE; KINETICS; LIPIDS; PARTICLE SIZE; PROGESTERONE; SOLUBILITY; STEARIC ACIDS; WATER;

EID: 0032918773     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00066-6     Document Type: Article

References (19)

1. Becirerevic-Lancan M., Skalko N. Hydrocortisone/cyclodextrin complex: complexation methods and complex incorporation in liposomes. STP Pharma Sci. 7:1997;343-347.
2. Cavalli R., Aquilano D., Carlotti M.E., Gasco M.R. Study by X-ray powder diffraction and differential scanning calorimetry of two model drugs, phenothiazine and nifedipine, incorporated into lipid nanoparticles. Eur. J. Pharm. Biopharm. 41:1995;329-333.
3. Cavalli R., Caputo O., Carlotti M.E., Trotta M., Scarnecchia C., Gasco M.R. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int. J. Pharm. 148:1997;47-54.
4. Cavalli R., Caputo O., Marengo E., Pattarino F., Gasco M.R. The effect of the components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules. Pharmazie. 53:1998;392-396.
5. Domb A.J. Long-acting injectable oxytetracycline lipospheres formulation. Int. J. Pharm. 124:1995;271-275.
6. Duchêne D. Cyclodextrins and their industrial uses. Editions de Santé Paris 1987. J. Pharm. Sci. 81:1987;521-523.
7. Irie T., Uekama K. Pharmaceutical applications of cyclodextrin. III. Toxicological Issues and safety evaluation. J. Pharm. Sci. 86:1997;147-162.
8. Irie T., Fukunaga K., Pitha J. Hydroxypropylcyclodextrins in parenteral use. I. Lipid dissolution and effects on lipid transfers in vitro. J. Pharm. Sci. 86:1992;147-162.
9. Koppel D.E. Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants. J. Chem. Phys. 57:1972;4814-4818.
10. Lemos-Senna E., Wouessidjewe D., Lesieur S., Duchêne D. Preparation of amphiphilic cyclodextrin nanospheres using the emulsification solvent evaporation method: influence of the surfactant on preparation and hydrophobic drug loading. Int. J. Pharm. 170:1998;119-128.
11. Loftsson T., Friöririksdottir H., Sigurõardottir A.M., Ueda H. The effect of water-soluble polymers on drug- cyclodextrin complexation. Int. J. Pharm. 110:1994;169-177.
12. McCormack B., Gregoriadis G. Drugs- in-cyclodextrins-in liposomes: a novel concept in drug delivery. Int. J. Pharm. 112:1994;249-258.
13. Preiss A., Mehnert W., Fromming K.H. Complexation of hydrocortisone with β-cyclodextrin and hydroxypropyl-β-cyclodextrin. Arch. Pharm. 327:1994;729-734.
14. Puglisi G., Santagati N.A., Pignatello R., Ventura C., Bottino F.A., Mangiafico S., Mazzone G. Inclusion complexation of 4-biphenylacetic acid with β-cyclodextrin. Drug. Dev. Ind. Pharm. 16:1990;395-413.
15. Rajewski R.A., Stella V. Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J.Pharm. Sci. 85:1996;1142-1169.
16. Schwartz C., Mehenert W., Lucks J.S., Müller R.H. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. Int. J. Pharm. 88:1992;53-56.
17. Tomida H., Yotsuyanagi T., Ikeda K. Solubilization of steroid hormones by polyoxy ethylene lauryl ether. Chem. Pharm. Bull. 26:1978;2832-2837.
18. Uekama K., Fujinaga F., Otagiri H., Yamasari M. Inclusion complexations of steroid hormones with cyclodextrins in water and in solid phase. Int. J. Pharm. 10:1982;1-15.
19. Westesen K., Siekmann B., Koch M.J.H. Investigation on physical state of lipid nanoparticles by synchroton radiation X-ray diffraction. Int. J. Pharm. 93:1993;199-204.